During the past decade, Marshall Cardiology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshall Cardiology" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Marshall Cardiology" are "Heart Failure" (3 trials) and "ASCVD" (1 trials). Many other conditions were trialed in "Marshall Cardiology" in a lesser frequency.

Most popular intervention types in "Marshall Cardiology" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Investigational LUX-Dx ICM Implant" (1 trials), "OPTIMIZER Smart System" (1 trials) and "µCor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marshall Cardiology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Marshall Cardiology". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Marshall Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Marshall Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".